Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisinopril crossover study of endothelial glycocalyx thickness in type 1 diabetes
NL-OMON23821Phase 4Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lisinopril in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Change in microvascular glycocalyx thickness. Planned start May 2008; status: not yet recruiting.
02
Drugs
lisinopril
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on NL-OMON23821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23821.